Form 8-K

8-K — VisionWave Holdings, Inc.

Accession: 0001731122-26-000886

Filed: 2026-06-25

Period: 2026-06-22

CIK: 0002038439

SIC: 7372 (SERVICES-PREPACKAGED SOFTWARE)

Item: Entry into a Material Definitive Agreement

Item: Unregistered Sales of Equity Securities

Item: Other Events

Item: Financial Statements and Exhibits

Documents

8-K — e7744_8-k.htm (Primary)

EX-10.1 — EXHIBIT 10.1 (e7744_ex10-1.htm)

EX-10.2 — EXHIBIT 10.2 (e7744_ex10-2.htm)

GRAPHIC (image_001.gif)

GRAPHIC (image_002.gif)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — FORM 8-K

8-K (Primary)

Filename: e7744_8-k.htm · Sequence: 1

false

0002038439

2026-06-22

0002038439

VWAV:CommonStockParValue0.01PerShareMember

2026-06-22

0002038439

VWAV:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50Member

2026-06-22

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

June 22, 2026

VisionWave Holdings, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware

001-42741

99-5002777

(State or other jurisdiction of incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

300 Delaware Ave., Suite 210 #301

Wilmington, DE 19801

(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area

code: (302) 305-4790

Not Applicable

(Former name or former address, if changed since last

report)

Check the appropriate box below if the Form 8-K filing

is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of

the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

VWAV

The Nasdaq Stock Market LLC

Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50

VWAVW

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an

emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities

Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark

if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards

provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 1.01 Entry into a Material Definitive Agreement.

On June 22, 2026, VisionWave Holdings, Inc. (the “Company”)

entered into an Assignment of Exchange Rights, Joinder and Partial Satisfaction of Note Agreement (the “Assignment Agreement”)

with Adrian Holdings S.R.L. (“Adrian”).

Background. The Company and SaverOne 2014 Ltd.

(“SaverOne”) are parties to an Exchange Agreement, dated as of January 26, 2026 (the “Exchange Agreement”), pursuant

to which SaverOne agreed to issue to the Company ordinary shares of SaverOne in three sequential stages in exchange for shares of the

Company’s common stock. The Stage 1 closing, the Stage 2 closing (the Milestone 1 Exchange), and the Stage 3 closing (the Milestone

2 Exchange) under the Exchange Agreement have each been consummated, following the achievement and certification of the applicable milestones

and the satisfaction of the conditions set forth in the Exchange Agreement. See Item 8.01 below. Separately, in connection with an Asset

Purchase Agreement, dated as of January 5, 2026 (the “Adrian APA”), the Company issued and delivered to Adrian a promissory

note in the original principal amount of $10,000,000 (the “Adrian Note”).

Assignment of right to receive shares. Pursuant

to the Assignment Agreement, the Company assigned to Adrian, effective immediately prior to and conditioned upon each of the Stage 2 closing

and the Stage 3 closing, all of the Company’s right, title, and interest in and to the right to receive 14,843,945,442 SaverOne

ordinary shares (the “Assigned Shares”), constituting a portion of the SaverOne ordinary shares otherwise issuable to the

Company at those closings under the Exchange Agreement (for rounding purposes SaverOne issued in actual 14,843,952,000 – as the

deposited shares must be divisible by 43,200, since it does not issue fractional ADSs). The Assignment Agreement provides that the Assigned

Shares are to be issued and delivered directly to Adrian (or a custodian designated by Adrian), such that the Assigned Shares are issued

to, and title passes directly to, Adrian without resting in the Company, and that the Company acts solely as a conduit and at no time

holds beneficial ownership of the Assigned Shares.

Consideration; partial reduction of the Adrian

Note. In consideration for the assignment, and effective upon the issuance of the Assigned Shares to Adrian at each applicable closing,

the outstanding principal amount of the Adrian Note will be reduced by an amount equal to 110% of the value of the Assigned Shares (the

“Note Reduction Amount”). Based on the Assigned Share value set forth in the Assignment Agreement, the aggregate Note Reduction

Amount is approximately $1.43 million, subject to adjustment as provided in the Assignment Agreement.

No change to SaverOne consideration. The Assignment

Agreement does not reduce, increase, or otherwise modify the aggregate number of SaverOne ordinary shares issuable, or the aggregate consideration

payable to SaverOne, under the Exchange Agreement, and the Company remains solely obligated to issue and deliver to SaverOne the shares

of the Company’s common stock constituting the consideration for the Stage 2 and Stage 3 SaverOne shares.

The foregoing description of the Assignment Agreement

does not purport to be complete and is qualified in its entirety by reference to the full text of the Assignment Agreement, a copy of

which is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference. The related Notice of Assignment

and Irrevocable Delivery Direction delivered by the Company to SaverOne is filed as Exhibit 10.2 and incorporated herein by reference.

Item 3.02 Unregistered Sales of Equity Securities.

The information set forth in Item 8.01 below regarding

the consummation of the Stage 2 closing and the Stage 3 closing is incorporated into this Item 3.02 by reference. At the Stage 2 closing

and the Stage 3 closing under the Exchange Agreement, on June 24, 2026 the Company issued and delivered to SaverOne, as the consideration

for the Stage 2 SaverOne Shares and the Stage 3 SaverOne Shares, an aggregate of 1,331,637 (which including issuance to SaverOne management

per article 1.7 of the exchange agreement) shares of the Company’s common stock, par value $0.01 per share (the “VisionWave

Shares”), consisting of VisionWave Shares having an aggregate value of approximately $2,743,137 issued at the Stage 2 closing and

VisionWave Shares having an aggregate value of approximately $1,513,726 issued at the Stage 3 closing, in each case with the number of

shares determined based on the VWAV Average Price as provided in the Exchange Agreement (the sum of $100,000 based on $5.34 VWAP price

was set aside and was not deliver, pending SAverOne provide the management names that those cshare supposed to be allocated to). The VisionWave

Shares were issued in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended

(the “Securities Act”), and/or Rule 506(b) of Regulation D thereunder, as a transaction by an issuer not involving any public

offering, to an “accredited investor” that made customary investment representations. No underwriters were involved, and no

underwriting discounts or commissions were paid. The VisionWave Shares are “restricted securities” within the meaning of Rule

144 under the Securities Act and bear a customary restrictive legend.

Item 8.01 Other Events.

Completion of the Stage 2 and Stage 3 Closings.

On June 22, 2026, the Company and SaverOne consummated the Stage 2 closing (the Milestone 1 Exchange) and the Stage 3 closing (the

Milestone 2 Exchange) under the Exchange Agreement, following the achievement and certification of Milestone 1 and Milestone 2. At those

closings, SaverOne issued the Stage 2 SaverOne Shares and the Stage 3 SaverOne Shares and, in accordance with the Assignment Agreement

and the related Delivery Direction, the Assigned Shares were issued and delivered directly to Adrian (or its designated custodian), with

the balance of such shares issued to the Company. In exchange, the Company issued to SaverOne the VisionWave Shares described in Item

3.02 above. After giving effect to the foregoing, including the assignment of the Assigned Shares to Adrian, the Company beneficially

owns approximately 41% of SaverOne’s issued and outstanding ordinary shares. The Company does not control SaverOne, will not consolidate

SaverOne in the Company’s financial statements, and intends to account for its investment in SaverOne [under the equity method of

accounting].

On June 22, 2026, in connection with the Assignment

Agreement, the Company delivered to SaverOne and its transfer agent a Notice of Assignment and Irrevocable Delivery Direction directing

that the Assigned Shares allocable to each of the Stage 2 closing and the Stage 3 closing be issued and delivered directly to Adrian (or

its designated custodian). A copy of the Notice of Assignment and Irrevocable Delivery Direction is filed as Exhibit 10.2 to this Current

Report on Form 8-K and incorporated herein by reference.

Forward-Looking Statements.

This Current Report on Form 8-K contains forward-looking

statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act

of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements

regarding the Company’s ownership interest in SaverOne, the Company’s expectations regarding the accounting treatment of,

and the non-consolidation of, its investment in SaverOne, the reduction of the Adrian Note, the integration of the parties’ technologies,

and the Company’s future business plans and results. These statements are based on the Company’s current expectations and

are subject to risks and uncertainties, including those described in the Company’s filings with the Securities and Exchange Commission,

including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. Actual results may differ materially

from those expressed or implied. The Company undertakes no obligation to update any forward-looking statements except as required by law.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.

Description

10.1

Assignment of Exchange Rights, Joinder and Partial Satisfaction of Note Agreement, dated June 22, 2026, by and between VisionWave Holdings, Inc. and Adrian Holdings S.R.L.

10.2

Notice of Assignment and Irrevocable Delivery Direction, dated June 22, 2026, from VisionWave Holdings, Inc. to SaverOne 2014 Ltd.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange

Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

VISIONWAVE HOLDINGS, INC.

Date: June 25, 2026

By: /s/ Douglas Davis

Name: Douglas Davis

Title: Executive Chairman and Chief Executive Officer

(Principal Executive Officer)

EX-10.1 — EXHIBIT 10.1

EX-10.1

Filename: e7744_ex10-1.htm · Sequence: 2

EXHIBIT 10.1

ASSIGNMENT

OF EXCHANGE RIGHTS, JOINDER AND PARTIAL SATISFACTION OF NOTE AGREEMENT

This Assignment of Exchange Rights,

Joinder and Partial Satisfaction of Note Agreement (this “Agreement”) is entered into as of June 22, 2026 (the

“Effective Date”), by and between:

VisionWave Holdings, Inc., a corporation organized

and existing under the laws of the State of Delaware (“VisionWave”);

Adrian Holdings S.R.L., a company organized

and existing under the laws of the Republic of Costa Rica (“Adrian”).

VisionWave and

Adrian are each referred to herein as a “Party” and collectively as the “Parties.” Capitalized terms used but

not otherwise defined herein shall have the meanings ascribed to them in the Exchange Agreement (as defined below).

RECITALS

WHEREAS, VisionWave

and SaverOne are parties to that certain Exchange Agreement, dated as of January 26, 2026 (the “Exchange Agreement”), pursuant

to which, among other things, SaverOne agreed to issue to VisionWave SaverOne Ordinary Shares in three sequential Stages in exchange for

shares of VisionWave Common Stock;

WHEREAS, the

Stage 1 Closing under the Exchange Agreement has been consummated, and the Stage 2 Closing (the Milestone 1 Exchange) and the Stage 3

Closing (the Milestone 2 Exchange) remain to be consummated, at which Closings SaverOne is to issue to VisionWave the Stage 2 SaverOne

Shares and the Stage 3 SaverOne Shares, respectively (collectively, the “Remaining SaverOne Shares”);

WHEREAS, VisionWave

and Adrian are parties to that certain Asset Purchase Agreement, dated as of January 5, 2026 (the “Adrian APA”), in connection

with which VisionWave issued and delivered to Adrian a promissory note in the original principal amount of USD $10,000,000, dated January

5, 2026 (the “Adrian Note”);

WHEREAS, VisionWave

desires to assign and transfer to Adrian, and Adrian desires to acquire, the right to receive a portion of the Remaining SaverOne Shares

otherwise issuable to VisionWave at the Stage 2 Closing and/or the Stage 3 Closing (such assigned shares, the “Assigned Shares”),

in each case on the terms and subject to the conditions set forth herein;

WHEREAS, in

consideration for the Assigned Shares, VisionWave and Adrian have agreed that the outstanding principal amount of the Adrian Note shall

be reduced by an amount equal to the value of the Assigned Shares plus ten percent (10%), as further set forth herein; and

WHEREAS, Section

9.8 of the Exchange Agreement contains no provision rendering an assignment made without the consent of the other party thereto void

or invalid; accordingly, the assignment of the right to receive the Assigned Shares effected hereby is intended to be, and

shall be, effective as between VisionWave and Adrian upon the terms set forth herein, and VisionWave shall provide SaverOne with

notice of such assignment and an irrevocable direction to deliver the Assigned Shares to Adrian, as provided herein.

NOW, THEREFORE,

in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration, the receipt

and sufficiency of which are hereby acknowledged, the Parties agree as follows:

1. ASSIGNMENT OF EXCHANGE RIGHTS; JOINDER

1.1 Partial

Assignment. Effective immediately prior to, and conditioned upon the occurrence of, the applicable

Closing (as provided in Section 4), VisionWave hereby irrevocably assigns, transfers, and conveys to Adrian all of VisionWave’s

right, title, and interest in and to the right to receive 14,843,945,442 SaverOne Ordinary Shares (the “Assigned Shares”),

constituting a portion of the Remaining SaverOne Shares otherwise issuable to VisionWave at the Stage 2 Closing and/or the Stage 3 Closing

under Section 1.2 of the Exchange Agreement. The number of Assigned Shares, and the allocation thereof between the Stage 2 Closing and

the Stage 3 Closing, shall be as set forth on Schedule A hereto. For the avoidance of doubt, VisionWave retains all of its right, title,

and interest in and to the balance of the Remaining SaverOne Shares not constituting Assigned Shares. The assignment effected hereby is

intended to vest the right to receive the Assigned Shares in Adrian immediately prior to issuance, such that the Assigned Shares are issued

directly to, and title thereto passes directly to, Adrian without ever resting in VisionWave. VisionWave acts solely as a conduit with

respect to the Assigned Shares and at no time holds, acquires, or retains beneficial ownership of the Assigned Shares.

1.2 Joinder.

Adrian hereby agrees, for the benefit of VisionWave (and, to the extent it may be enforced by SaverOne as an intended beneficiary of this

Section 1.2, for the benefit of SaverOne), to be bound by and to comply with the investment representations, transfer restrictions, and

legend requirements applicable to a holder of the Assigned Shares set forth in Article 8 and Section 3.17 of the Exchange Agreement, in

each case mutatis mutandis and as if Adrian were the holder named therein with respect to the Assigned Shares. This Section 1.2 constitutes

a unilateral undertaking by Adrian and does not require, and shall not be construed to require, the execution of this Agreement by, or

any other act of, SaverOne. Except as expressly set forth herein, Adrian shall not acquire any rights, or assume any obligations, under

the Exchange Agreement.

1.3 No

Assumption of VisionWave Payment Obligation. Notwithstanding the assignment effected hereby,

the obligation to issue and deliver to SaverOne the shares of VisionWave Common Stock constituting the consideration for the Stage 2 SaverOne

Shares and the Stage 3 SaverOne Shares under the Exchange Agreement shall remain the sole obligation of VisionWave, and Adrian shall have

no obligation in respect thereof.

2. DELIVERY DIRECTION; CONDUIT; NO MOMENTARY OWNERSHIP

2.1 Delivery

Direction. No later than five (5) Business Days prior to each of the Stage 2 Closing and the

Stage 3 Closing, VisionWave shall deliver to SaverOne (and, as applicable, to SaverOne’s transfer agent) an irrevocable written

direction (the “Delivery Direction”) directing SaverOne to issue and deliver the Assigned Shares allocable to such Closing

directly to Adrian (or to a custodian designated in writing by Adrian to receive and hold the Assigned Shares as agent for Adrian). The

Delivery Direction is given as a notice and direction pursuant to Section 9.4 of the Exchange Agreement and does not require, request,

or depend upon the consent of SaverOne. VisionWave shall give the Delivery Direction effect through its own rights as the party entitled

to issuance under the Exchange Agreement and shall not be required to obtain SaverOne’s agreement or signature in connection therewith.

2.2 Direct

Issuance. The Parties intend that, at the Stage 2 Closing and the Stage 3 Closing, as applicable,

and in accordance with the Delivery Direction, (a) the Assigned Shares allocable to such Closing be issued and delivered directly to Adrian

(or its designated custodian), and (b) the balance of the Remaining SaverOne Shares issuable at such Closing be issued to VisionWave,

in each case against VisionWave’s issuance and delivery to SaverOne of the shares of VisionWave Common Stock constituting the consideration

for such Stage as required under the Exchange Agreement. If, notwithstanding the Delivery Direction, any Assigned Shares are issued or

delivered to VisionWave (or registered in VisionWave’s name) rather than to Adrian, then VisionWave shall receive and hold such

Assigned Shares solely as conduit, bare nominee, and agent for, and in trust for the exclusive

benefit of, Adrian; VisionWave shall acquire no beneficial ownership of, and no voting, economic, or other beneficial rights in, such

Assigned Shares; and VisionWave shall, without further consideration, immediately transfer and deliver such Assigned Shares to Adrian.

Title to any Assigned Shares so issued to VisionWave shall be deemed to pass simultaneously through VisionWave to Adrian, without resting

in VisionWave, at the instant of issuance.

2.3 No

Change to SaverOne Consideration. Nothing in this Agreement shall reduce, increase, or otherwise

modify the aggregate number of SaverOne Ordinary Shares issuable, or the aggregate consideration payable to SaverOne, under the Exchange

Agreement; the sole effect of this Agreement with respect to such issuance is to direct a portion of the Remaining SaverOne Shares to

Adrian rather than to VisionWave.

3. CONSIDERATION; PARTIAL REDUCTION OF THE ADRIAN NOTE

3.1 Note

Reduction. In consideration for the Assigned Shares, effective upon the issuance of the Assigned

Shares to Adrian at the applicable Closing, the outstanding principal amount of the Adrian Note shall be automatically reduced by the

Note Reduction Amount (as defined below), without any further action by any Party.

3.2 Note

Reduction Amount. The “Note Reduction Amount” means an amount equal to one hundred

ten percent (110%) of the Assigned Share Value (that is, the Assigned Share Value plus an additional ten percent (10%) thereof). The “Assigned

Share Value” means the value of the Assigned Shares, as determined by VisionWave in good faith based on the valuation methodology

applied to the SaverOne Shares issued at the applicable Stage under the Exchange Agreement, or as otherwise agreed in writing by VisionWave

and Adrian. The Assigned Share Value and the resulting Note Reduction Amount shall be as set forth on Schedule A hereto.

3.3 Application;

Treatment as Payment. The Note Reduction Amount shall be applied to reduce the outstanding principal

amount of the Adrian Note and, unless VisionWave and Adrian agree otherwise in writing, shall be treated as a payment of principal under

the Adrian Note for all purposes, including for purposes of any reduction in the interest rate of the Adrian Note that is conditioned

on payments of principal thereunder. Promptly following each applicable Closing, VisionWave and Adrian shall execute and deliver an acknowledgment

or allonge to the Adrian Note reflecting the reduced outstanding principal balance.

3.4 No

Other Modification of the Adrian Note or Adrian APA. Except for the reduction of the outstanding

principal amount of the Adrian Note as expressly provided herein, the Adrian Note and the Adrian APA shall remain in full force and effect

in accordance with their respective terms.

4. CLOSING; CONDITIONS

4.1 Timing.

The assignment of the right to receive the Assigned Shares allocable to each of the Stage 2 Closing

and the Stage 3 Closing shall be effective immediately prior to, and the issuance of the Assigned Shares and the corresponding reduction

of the Adrian Note shall occur upon, the applicable Stage 2 Closing or Stage 3 Closing under the Exchange Agreement, in each case conditioned

upon the occurrence of such Closing (including the achievement and certification of the applicable Milestone and the satisfaction or waiver

of the conditions to such Closing set forth in the Exchange Agreement).

4.2 Allocation

Notice. VisionWave may, by written notice to SaverOne and Adrian delivered no later than five

(5) Business Days prior to the applicable Closing, specify or update the number of Assigned Shares allocable to such Closing, consistent

with the aggregate number of Assigned Shares set forth on Schedule A.

4.3 Nasdaq

and Regulatory Compliance. The Parties’ respective obligations hereunder are subject to

compliance with the applicable rules of The Nasdaq Stock Market, applicable securities laws, and the receipt of any required regulatory

approvals.

5. REPRESENTATIONS AND WARRANTIES

5.1 Mutual. Each

Party represents and warrants, as to itself, that: (a) it is duly organized, validly existing, and in good standing under the laws

of its jurisdiction of organization; (b) it has full power and authority to execute, deliver, and perform this Agreement; (c)

this Agreement has been duly executed and delivered by it and constitutes its legal, valid, and binding obligation, enforceable

against it in accordance with its terms, subject to applicable bankruptcy, insolvency,

and similar laws and general principles of equity; and (d) its execution, delivery, and performance of this Agreement do not violate

its organizational documents or any material agreement or applicable law to which it is subject.

5.2 VisionWave.

VisionWave represents and warrants that it has good and valid title to, and the right to assign,

the right to receive the Assigned Shares, free and clear of all Liens (other than restrictions imposed by applicable securities laws),

and that it has not previously assigned, transferred, pledged, or otherwise encumbered such right.

5.3 Adrian.

Adrian represents and warrants that: (a) it is acquiring the Assigned Shares for its own account, for investment purposes, and not with

a view to, or for offer or sale in connection with, any distribution thereof in violation of applicable securities laws; (b) it understands

that the Assigned Shares will be “restricted securities,” have not been registered under the Securities Act or any other applicable

securities laws, and may not be offered, sold, or otherwise transferred except pursuant to an effective registration statement or an applicable

exemption therefrom; (c) it has such knowledge and experience in financial and business matters as to be capable of evaluating the merits

and risks of acquiring the Assigned Shares and is able to bear the economic risk thereof; and (d) it consents to the imprinting of a customary

restrictive legend on any certificate or book- entry notation evidencing the Assigned Shares.

6. MISCELLANEOUS

6.1 Governing

Law; Dispute Resolution. This Agreement shall be governed by, and construed in accordance with,

the law specified in, and shall be subject to the jurisdiction and dispute resolution provisions set forth in, Sections 9.1 and 9.10 of

the Exchange Agreement, which are incorporated herein by reference mutatis mutandis.

6.2 Entire

Agreement. This Agreement, together with the Exchange Agreement, the Adrian APA, and the Adrian

Note, constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior agreements,

understandings, and negotiations with respect thereto.

6.3 Amendments;

Waivers. No amendment, modification, or waiver of any provision of this Agreement shall be effective

unless in writing and signed by each Party (or, in the case of a waiver, by the Party against whom the waiver is to be effective).

6.4 No

Other Amendment; Conflict. Except as expressly set forth herein, the Exchange Agreement remains

in full force and effect in accordance with its terms. In the event of any conflict between this Agreement and the Exchange Agreement

with respect to the Assigned Shares, this Agreement shall control.

6.5 Further

Assurances. Each Party shall execute and deliver such further documents and instruments, and

take such further actions, as may be reasonably necessary or appropriate to give effect to this Agreement.

6.6 Assignment.

No Party may assign this Agreement or any of its rights or obligations hereunder without the

prior written consent of the other Parties, except as otherwise permitted under the Exchange Agreement. This Agreement shall be binding

upon and inure to the benefit of the Parties and their respective successors and permitted assigns.

6.7 No

Third-Party Beneficiaries. This Agreement is for the sole benefit of the Parties and their permitted

successors and assigns, and nothing herein, express or implied, is intended to confer any rights or remedies upon any other Person.

6.8 Counterparts;

Electronic Signatures. This Agreement may be executed in one or more counterparts, each of which

shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed counterpart

by facsimile, PDF, or other electronic means shall be effective as delivery of a manually executed counterpart.

6.9 Notices.

All notices hereunder shall be given in the manner set forth in Section 9.4 of the Exchange Agreement,

to the addresses set forth therein or, in the case of Adrian, to the address set forth in the Adrian APA, or to such other address as

a Party may designate by notice.

6.10 Severability.

If any provision of this Agreement is held invalid, illegal, or unenforceable in any jurisdiction,

the remaining provisions shall remain in full force and effect, and such provision shall be reformed to the minimum extent necessary to

make it valid and enforceable.

IN WITNESS WHEREOF, the Parties have executed this Agreement

as of the Effective Date.

VISIONWAVE HOLDINGS, INC.

By:

Name:

Douglas Davis

Title:

Executive Chairman and CEO

ADRIAN HOLDINGS S.R.L.

By:

Name:

Mauricio Ernesto Lara Ramos

Title:

Manager

SCHEDULE A

ASSIGNED SHARES AND NOTE REDUCTION AMOUNT

This Schedule A forms part of, and is subject

to the terms of, the Agreement. The figures below are to be completed by VisionWave management prior to the applicable Closing.

Item

Amount

Total Assigned Shares (SaverOne Ordinary Shares)

14,843,945,442

Assigned Share Value

USD $1,302,281

Note Reduction Amount (110% of Assigned Share Value)

USD $1,432,509*

* Subject to adjustment; to be finalized

by Adrian and VisionWave within ten (10) business days.

EX-10.2 — EXHIBIT 10.2

EX-10.2

Filename: e7744_ex10-2.htm · Sequence: 3

EXHIBIT 10.2

VISIONWAVE HOLDINGS, INC.

300 Delaware Ave, Suite 210#301, Wilmington,

Delaware 19801

June 22, 2026

BY EMAIL AND OVERNIGHT COURIER

SaverOne 2014 Ltd.

Em Hamoshavot Rd 94, Petah Tikva, Israel Attention: Ori

Gilboa, Chief Executive Officer

and to: SaverOne’s duly appointed transfer agent / share

registrar

Re: Notice of Assignment and Irrevocable Delivery Direction

under the Exchange Agreement dated January 26, 2026

Ladies and Gentlemen:

Reference is made to that certain Exchange

Agreement, dated as of January 26, 2026 (the “Exchange Agreement”), by and between VisionWave Holdings, Inc. (“VisionWave”)

and SaverOne 2014 Ltd. (“SaverOne”). Capitalized terms used but not defined in this letter have the meanings given in the

Exchange Agreement. This letter is delivered as a notice and direction pursuant to Section 9.4 of the Exchange Agreement.

This letter sets

forth (a) the assignment by VisionWave of a portion of its right to receive the Remaining SaverOne Shares, and (b) VisionWave’s

irrevocable direction regarding the issuance and delivery of such shares, in each case in accordance with SaverOne’s prior written

consent pursuant to Section 9.8 of the Exchange Agreement.

1. Notice of Assignment. VisionWave has irrevocably assigned and transferred to Adrian

Holdings S.R.L. (“Adrian”), effective

immediately prior to each applicable Closing, all of VisionWave’s right, title, and interest in and to the right to receive 14,843,945,442

SaverOne Ordinary Shares (the “Assigned Shares”), constituting a portion of the Remaining SaverOne Shares otherwise issuable

to VisionWave at the Stage 2 Closing and/or the Stage 3 Closing under Section 1.2 of the Exchange Agreement.

2. Irrevocable Delivery Direction. VisionWave hereby irrevocably directs

SaverOne, and SaverOne’s transfer agent or share registrar, to issue and deliver the Assigned Shares allocable to each of the Stage

2 Closing and the Stage 3 Closing directly to Adrian (or to a custodian designated in writing by Adrian to receive and hold the Assigned

Shares as agent for Adrian), in book-entry form, registered in the name of Adrian (or such custodian), bearing the restrictive legend

set forth in Section 8.1 of the Exchange Agreement. The balance of the Remaining SaverOne Shares issuable at each such Closing shall continue

to be issued and delivered to VisionWave. Adrian’s registration and account details, and any designated custodian, will be provided

to SaverOne and its transfer agent not later than five (5) Business Days prior to the applicable Closing.

3. No change to SaverOne’s consideration or

aggregate issuance. This direction does not reduce, increase, or otherwise modify the aggregate number of SaverOne Ordinary Shares

issuable, or the aggregate consideration payable to SaverOne, under the Exchange Agreement. VisionWave remains solely obligated to issue

and deliver to SaverOne the shares of VisionWave Common Stock constituting the consideration for the Stage 2 SaverOne Shares and the Stage

3 SaverOne Shares. The issuance and delivery by SaverOne of the Assigned Shares to Adrian in accordance with this direction shall, to

the extent of the Assigned Shares so issued and delivered, constitute full and complete satisfaction and discharge of SaverOne’s

obligation under the Exchange Agreement to issue and deliver such Assigned Shares to VisionWave, and VisionWave shall have no further

claim against SaverOne in respect of such Assigned Shares. The sole effect of this direction is to route delivery of a portion of the

Remaining SaverOne Shares to Adrian rather than to VisionWave. SaverOne is therefore made whole in all respects and is not prejudiced

by giving effect to this direction.

4. Effectiveness of the assignment. Section 9.8

of the Exchange Agreement permits the assignment of rights thereunder with the prior written consent of the other party thereto, and SaverOne

has granted such consent with respect to the assignment effected hereby.

5. Conduit; no momentary ownership. The Assigned

Shares are to be issued directly to Adrian, and title is to pass directly to Adrian, without ever resting in VisionWave. If, notwithstanding

this direction, any Assigned Shares are issued or delivered to VisionWave (or registered in VisionWave’s name), VisionWave will

receive and hold such Assigned Shares solely as conduit, bare nominee, and agent for, and in trust for the exclusive benefit of, Adrian,

will acquire no beneficial ownership of such shares, and will immediately transfer and deliver such shares to Adrian, with title deemed

to pass simultaneously through VisionWave to Adrian without resting in VisionWave.

6. Securities-law compliance. Adrian has made

customary investment representations with respect to the Assigned Shares, has agreed to be bound by the investment representations, transfer

restrictions, and legend requirements of Article 8 and Section 3.17 of the Exchange Agreement (mutatis mutandis), and acknowledges that

the Assigned Shares are “restricted securities.” By signing this letter under “Agreed and Accepted” below, Adrian

confirms and agrees, directly for the benefit of SaverOne, to be bound by all such representations, undertakings, restrictions and requirements.

SaverOne shall be an express third-party beneficiary of this Section 6 and shall be entitled to enforce it directly against Adrian.

7. Request to transfer agent. SaverOne is requested to deliver, or to

instruct its transfer agent or share registrar to deliver, the Assigned Shares in accordance with this direction at each applicable Closing,

against VisionWave’s issuance and delivery to SaverOne of the corresponding VisionWave Common Stock consideration.

This direction is irrevocable and will

remain in effect until the Stage 2 Closing and the Stage 3 Closing have each been consummated or the Exchange Agreement is terminated.

Please direct any questions to the undersigned.

Very truly yours,

VISIONWAVE HOLDINGS, INC.

By:

Name:

Douglas Davis

Title:

Executive Chairman and CEO

cc:

Adrian Holdings S.R.L.

AGREED AND ACCEPTED:

ADRIAN HOLDINGS S.R.L.

By:

Name:

MAURICIO LARA

Title:

MANAGER

GRAPHIC

Filename: image_001.gif · Sequence: 4

Binary file (1606 bytes)

Download image_001.gif

GRAPHIC

Filename: image_002.gif · Sequence: 5

Binary file (469 bytes)

Download image_002.gif

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 11

v3.26.1

Cover

Jun. 22, 2026

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jun. 22, 2026

Entity File Number

001-42741

Entity Registrant Name

VisionWave Holdings, Inc.

Entity Central Index Key

0002038439

Entity Tax Identification Number

99-5002777

Entity Incorporation, State or Country Code

Entity Address, Address Line One

300 Delaware Ave.

Entity Address, Address Line Two

Suite 210 #301

Entity Address, City or Town

Wilmington

Entity Address, State or Province

Entity Address, Postal Zip Code

19801

City Area Code

(302)

Local Phone Number

305-4790

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

Common Stock, par value $0.01 per share

Title of 12(b) Security

Common Stock, par value $0.01 per share

Trading Symbol

VWAV

Security Exchange Name

NASDAQ

Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50

Title of 12(b) Security

Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50

Trading Symbol

VWAVW

Security Exchange Name

NASDAQ

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=VWAV_CommonStockParValue0.01PerShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=VWAV_RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtExercisePriceOf11.50Member

Namespace Prefix:

Data Type:

Balance Type:

Period Type: